| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/07/2001 | EP1080193A2 Multivalent t cell receptor complexes |
| 03/07/2001 | EP1080190A1 Calmodulin related protein |
| 03/07/2001 | EP1080188A2 Human nucleic acid sequences of uterus myoma tissue |
| 03/07/2001 | EP1080182A1 Amino acid modified polypeptides |
| 03/07/2001 | EP1080180A2 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1080113A1 Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases |
| 03/07/2001 | EP1080111A2 The induction of antiobiotic peptides by lait (scd14) protein |
| 03/07/2001 | EP1080106A1 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1079862A1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody |
| 03/07/2001 | EP1079858A2 Oral immunization with papillomavirus virus-like particles |
| 03/07/2001 | EP1079856A1 Humanized antibodies that recognize verotoxin ii and cell line producing same |
| 03/07/2001 | EP1079855A1 MURD PROTEIN AND GENE OF $i(PSEUDOMONAS AERUGINOSA) |
| 03/07/2001 | EP1079688A1 Method for expanding primate b cells selectively in immunocompromised mice and producing large numbers of antigen-specific b lymphocytes for the production of primate monoclonal antibodies |
| 03/07/2001 | EP0486526B2 Tumour necrosis factor binding ligands |
| 03/07/2001 | CN1286309A Process for preparing Ningnanmycin |
| 03/07/2001 | CN1286305A Human membrane transfer protein and its coding sequence |
| 03/07/2001 | CN1286304A Imprinting gene expressed in human adrenin and its coded protein |
| 03/07/2001 | CN1062909C Process for production of hydrolyzed vegetable proteins and product therefrom |
| 03/07/2001 | CN1062908C Polypeptides and DNAs encoding them |
| 03/07/2001 | CN1062907C Method for preparation of antibody materials |
| 03/06/2001 | US6197946 Nucleotide sequences coding hybrid albumin polypeptide; for production of heterologous polypeptide in hybrid animals |
| 03/06/2001 | US6197939 Polypeptide regulator; for use as a diagnostic tool in detection of tumors |
| 03/06/2001 | US6197937 Antibody which preferentially binds mammalian binding protein; for the treatment of atherosclerosis |
| 03/06/2001 | US6197931 Human marco scavenger receptor |
| 03/06/2001 | US6197930 Polypeptide for use in organ preservation, cryopreservation, for surgical pretreatment to prevent injury due to inflammation; antiischemic agents |
| 03/06/2001 | US6197929 Bacterial polypeptide for use in prevention of bacterial infection |
| 03/06/2001 | US6197925 NF-AT polypeptides and polynucleotides |
| 03/06/2001 | US6197755 Compositions and methods for delivery of genetic material |
| 03/06/2001 | US6197747 Insertion of the Bacillus thuringiensis crystal protein gene into plant colonizing microorganisms and their use |
| 03/06/2001 | US6197591 Nucleotide sequence which control the transcription of a preferential antibiotic |
| 03/06/2001 | US6197582 Development of human monoclonal antibodies and uses thereof |
| 03/06/2001 | US6197571 Protein polysaccharide 0041 |
| 03/06/2001 | US6197551 Spoil-1 protein and nucleic acid molecules and uses therefor |
| 03/06/2001 | US6197549 Amino acid and nucleotide sequences of aminoacylase from staphylococcus; drug screening of bactericides for treatment of infections |
| 03/06/2001 | US6197547 Trigger factor expression plasmids |
| 03/06/2001 | US6197541 Nucleic acid which codes for mammalian receptor having seven transmembrane domains; drug screening of anticoagulants and wound healing agents; diagnosis of cardiovascular disorders; treatment of restenosis and unstable angina |
| 03/06/2001 | US6197536 Methodology to produce, and purify and assay polypeptides with the proteolytic activity of the HCV NS3 protease |
| 03/06/2001 | US6197525 Kit for detection of interleukin-17, interleukin-17 receptor, antagonists, or mimetics; includes receptor protein of defined amino acid sequence and a detecting reagent; for identifying immunosuppressants |
| 03/06/2001 | US6197524 Methods for detecting, identifying, isolating, and selectively labelling and targeting TH1 lymphocyte by means of the LAG-3 protein |
| 03/06/2001 | US6197521 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 03/06/2001 | US6197500 For hybridization probes and amplification primers used to diagnose the presence or absence of a fragile x allele in an individual |
| 03/06/2001 | US6197496 Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins gp300, p200, and p90/80 |
| 03/06/2001 | US6197312 Surface antigen |
| 03/06/2001 | US6197310 Causative agent of the mystery swine disease, vaccine compositions and diagnostics kits |
| 03/06/2001 | US6197301 Compositions and methods for the prevention and diagnosis of Lyme disease |
| 03/06/2001 | US6197300 ftsZ |
| 03/06/2001 | US6197297 Monoclonal antibody specific to polypeptide which induces interferon-gamma production |
| 03/06/2001 | US6197069 Adrenomedullin receptor polynucleotides |
| 03/06/2001 | CA1341198C Monoclonal antibodies against melanoma-associated antigens, hybrid cell lines producing these antibodies, and use therefor |
| 03/06/2001 | CA1341197C Gm-csf protein, its derivatives, the preparation of proteins of this type, and their use |
| 03/01/2001 | WO2001014578A1 Methods for the detection, analysis and isolation of nascent proteins |
| 03/01/2001 | WO2001014577A1 Molecular cloning of a galanin like 7tm receptor (axor40) |
| 03/01/2001 | WO2001014570A1 Activatable recombinant neurotoxins |
| 03/01/2001 | WO2001014564A2 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 03/01/2001 | WO2001014556A1 Novel b7-4 molecules and uses therefor |
| 03/01/2001 | WO2001014554A1 G protein-coupled receptor expressed in brain |
| 03/01/2001 | WO2001014551A1 NOVEL bHLH TYPE TRANSCRIPTION FACTOR GENE DEC2 |
| 03/01/2001 | WO2001014548A2 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | WO2001014547A1 Novel abc transporter and uses thereof |
| 03/01/2001 | WO2001014545A1 Pgrp-l polynucleotides, polypeptides, and antibodies |
| 03/01/2001 | WO2001014536A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 03/01/2001 | WO2001014533A2 Phosphomevalonate kinase (pmk) gene (erg8) from candida albicans |
| 03/01/2001 | WO2001014529A1 Compositions and methods for improved cell culture |
| 03/01/2001 | WO2001014528A1 Method of preparing immune response-inducing dendritic cells |
| 03/01/2001 | WO2001014522A1 Novel yeast variants and process for producing glycoprotein containing mammalian type sugar chain |
| 03/01/2001 | WO2001014521A1 A method for decreasing the foam formation during cultivation of a microorganism |
| 03/01/2001 | WO2001014421A1 Homologs of a pneumococcal protein and fragments for vaccines |
| 03/01/2001 | WO2001014418A2 p193 PROTEINS AND NUCLEIC ACIDS, AND USES THEREOF |
| 03/01/2001 | WO2001014417A2 Pesticidal proteins |
| 03/01/2001 | WO2001014416A2 Synthetic papillomavirus genes optimized for expression in human cells |
| 03/01/2001 | WO2001014415A2 Egfh2 genes and gene products |
| 03/01/2001 | WO2001014414A2 Human abc2 transporter and uses thereof |
| 03/01/2001 | WO2001014411A1 Recombinant subunit vaccine |
| 03/01/2001 | WO2001014407A2 Refolding of membrane proteins, using two different detergents |
| 03/01/2001 | WO2001013714A2 Prostatic cell line and animal model of a prostatic tumor |
| 03/01/2001 | WO2000077208A3 Gustatory receptors in drosophila |
| 03/01/2001 | WO2000073449B1 Dna encoding snorf33 receptor |
| 03/01/2001 | WO2000073445A3 Interleukin-1-receptor associated kinase-3 (irak3) |
| 03/01/2001 | WO2000065060A3 Dna sequence and recombinant production of a graminae allergen |
| 03/01/2001 | WO2000049413A3 Rapid assay for arthropod-borne disease vectors and pathogens |
| 03/01/2001 | WO2000049162A8 Compositions and methods for non-targeted activation of endogenous genes |
| 03/01/2001 | WO2000049038A3 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 03/01/2001 | WO2000048638A3 Multi-mutant diphtheria toxin vaccines |
| 03/01/2001 | WO1999036537A3 Fatty acid transport proteins |
| 03/01/2001 | DE19938703A1 Production of proteins, especially recombinant human chymotrypsinogen, by fermentation and subsequent extraction comprises using a fermentation medium and extraction system having the same pH |
| 03/01/2001 | CA2589418A1 Human ctla-4 antibodies and their uses |
| 03/01/2001 | CA2383371A1 P193 proteins and nucleic acids, and uses thereof |
| 03/01/2001 | CA2383074A1 Novel abc transporter and uses thereof |
| 03/01/2001 | CA2383073A1 Compositions and methods for improved cell culture |
| 03/01/2001 | CA2383063A1 Human abc2 transporter and uses thereof |
| 03/01/2001 | CA2382795A1 Homologs of a pneumococcal protein and fragments for vaccines |
| 03/01/2001 | CA2382468A1 A method for decreasing foam formation during cultivation of trichoderma |
| 03/01/2001 | CA2382204A1 Prostatic cell line and use thereof to obtain an established prostatic cancer in an animal |
| 03/01/2001 | CA2382184A1 Novel yeast mutants and process for producing glycoprotein containing mammalian type sugar chain |
| 03/01/2001 | CA2382183A1 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | CA2382176A1 Recombinant subunit vaccine |
| 03/01/2001 | CA2382146A1 Pgrp-l polynucleotides, polypeptides, and antibodies |
| 03/01/2001 | CA2382123A1 Novel polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 03/01/2001 | CA2381991A1 Synthetic human papillomavirus genes |
| 03/01/2001 | CA2380457A1 Activatable recombinant neurotoxins |